Incidence of immune checkpoint inhibitor-related myositis
Not Applicable
- Conditions
- Solid tumors
- Registration Number
- JPRN-UMIN000044960
- Lead Sponsor
- Yokohama City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12866
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Systematic review or meta-analysis articles. (2) Retrospective analysis. (3) Single prospective cohort study without a control group. (4) Non-RCT. (5) The republished research literature is excluded unless the research includes new findings related to adverse events listed in inclusion criteria. (6) Studies with no or insufficient safety results at the time of the literature search. (7) Studies published in languages other than English.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The odds ratio (OR) of any grade myositis will be calculated. Meta-analysis will be performed to compare the incidence of myositis between the treatment arm with ICIs and the arm with chemotherapy.
- Secondary Outcome Measures
Name Time Method